Predominantly hemorrhagic choroidal neovascular lesion from exsudative age-related macular degeneration treated with intravitreal ranibizumab therapy / Lesão neovascular predominantemente hemorrágica da degeneração macular relacionada à idade, tratada com ranibizumab intravítrea
Rev. bras. oftalmol
;
72(3): 185-187, maio-jun. 2013. ilus
Article
in English
| LILACS
| ID: lil-690247
ABSTRACT
The authors relate a predominantly hemorrhagic choroidal neovascular lesion from neovascular. Age-related macular degeneration patient case treated with intravitreal ranibizumab therapy. Monthly ranibizumab (six intravitreal injections) displayed a promising response but this limited report is insufficient to guarantee the indication for all predominantly hemorrhagic choroidal neovascular lesion from neovascular age-related macular degeneration. Further studies will be necessary for complete validation of our results for all predominantly hemorrhagic choroidal neovascular lesions from CNV due to AMD...
RESUMO
Os autores apresentam um caso de paciente com lesão neovascular predominantemente hemorrágica com degeneração macular relacionada à idade, tratada mensalmente com injenções intravítrea com ranibizumab. Discutem sua evolução, que apesar da boa resposta terapêutica, necessita de maiores estudos para confirmação de seus resultados...
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Choroidal Neovascularization
/
Intravitreal Injections
/
Immunologic Factors
/
Macular Degeneration
/
Antibodies, Monoclonal
Limits:
Aged
/
Female
/
Humans
Language:
English
Journal:
Rev. bras. oftalmol
Journal subject:
Ophthalmology
Year:
2013
Type:
Article
Affiliation country:
Brazil
/
United States
Institution/Affiliation country:
Private Practice/BR
/
University of Iowa/US
Similar
MEDLINE
...
LILACS
LIS